Medizone Intl. (fka MZEIQ)

[Zeppo]

I will repeat myself that EPA approval should make shareholders go back and take a second look at all the proxies. I expect shareholders to approve the increase in authorized common shares. Why then does management need to keep the preferred stock issue that is an obvious "poison pill" to unsolicited suitors? A buyout is the best solution for shareholders, yet management recommends a vote "against" rescinding the preferred offering. Look at the company infrastructure and tell me how the company plans to go it alone. Where's the plan? While we're re-perusing the proxies, maybe there are a couple of other votes that also could stand to be changed.